Skip to content
PIL Logo

Trobalt

Last Updated on eMC 18-May-2016 View changes  | GlaxoSmithKline UK Contact details

The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.

Please click on the link to the left to view the PIL in PDF format.

Discontinued Items
VIEW

The preparations being discontinued are:

  • Trobalt 100mg tablets (GlaxoSmithKline UK Ltd)
  • Trobalt 200mg tablets (GlaxoSmithKline UK Ltd)
  • Trobalt 300mg tablets (GlaxoSmithKline UK Ltd)
  • Trobalt 400mg tablets (GlaxoSmithKline UK Ltd)
  • Trobalt 50mg tablets (GlaxoSmithKline UK Ltd)
  • Trobalt tablets starter pack (GlaxoSmithKline UK Ltd)

The pharmaceutical company has decided to discontinue the product and so it may not be available in the future.  This document has been left on the eMC for information purposes.

CLOSE THIS PANEL

Company contact details

GlaxoSmithKline UK

Company image
Address

Stockley Park West, Uxbridge, Middlesex, UB11 1BT

Fax

+44 (0)208 990 4328

Medical Information e-mail
Telephone

0800 221 441

E-mail
Customer Care direct line

0800 221 441

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

retigabine

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue